XML 64 R50.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation - Schedule of Stock Option Plan Activity (Details) - USD ($)
12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Schedule of Stock Option Plan Activity [Abstract]    
Number of Options, Outstanding 2,814,096 1,708,427
Weighted Average Exercise Price, Outstanding $ 3.13 $ 4.34
Weighted- Average Remaining Contractual Term (years), Outstanding 8 years 3 months 18 days 7 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding [1] $ 22,685 $ 20,064
Number of Options, Granted 3,336,571 1,225,669
Weighted Average Exercise Price, Granted $ 0.6 $ 1.26
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Options, Forfeited/Cancelled (67,500) (120,000)
Weighted Average Exercise Price, Forfeited/Cancelled $ 1.82 $ 1.33
Number of Options, Outstanding 6,083,167 2,814,096
Weighted Average Exercise Price, Outstanding $ 1.76 $ 3.13
Aggregate Intrinsic Value, Outstanding [1] $ 999,882 $ 22,685
Number of Options, Vested and expected to vest at September 30, 2025 6,083,167  
Weighted Average Exercise Price, Vested and expected to vest at September 30, 2025 $ 1.76  
Weighted- Average Remaining Contractual Term (years), Vested and expected to vest at September 30, 2025 8 years 3 months 18 days  
Aggregate Intrinsic Value, Vested and expected to vest at September 30, 2025 [1] $ 999,882  
Number of Options, Vested and exercisable at September 30, 2025 2,172,035  
Weighted Average Exercise Price, Vested and exercisable at September 30, 2025 $ 3.62  
Weighted- Average Remaining Contractual Term (years), Vested and exercisable at September 30, 2025 6 years 4 months 24 days  
Aggregate Intrinsic Value, Vested and exercisable at September 30, 2025 [1] $ 44,288  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of our common stock as of September 30, 2025 and 2024 of $0.89 and $0.99 per share, respectively. As of September 30, 2025 and 2024, 2,772,156 and 2,780,581 outstanding options, respectively, had no intrinsic value.